|
⚲
|
| Keyboard |
| Cohen Charles J
✚
|
|
|---|---|
| CIK # | 0001619967 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001619967] | |
| 4 | [0001619967] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cohen Charles J | |
| Xenon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2018-12-11 | Option exercise | 4,115 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2018-12-11 | Option exercise | 4,115 | $3.07 | 12,633 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2018-12-11 | Tax withheld | 1,644 | $7.00 | 11,508 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2018-03-12 | Grant | 40,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2018-02-12 | Tax withheld | 22,669 | $3.50 | 79,342 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2018-02-12 | Option exercise | 26,748 | $3.71 | 99,235 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2018-02-12 | Option exercise | 26,748 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2017-10-23 | Grant | 11,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2017-03-13 | Grant | 20,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2016-03-11 | Grant | 25,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2015-12-18 | Grant | 15,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option (Right to Buy) · derivative
|
2015-03-17 | Grant | 35,000 | $0.00 |